Last Minutes! Coronavirus vaccine from U.S. pharmaceutical company Moderna Inc: 94.5 percent effective

Last minutes! U.S. pharmaceutical company Moderna Inc has announced that the vaccine it developed is effective in preventing coronavirus. "According to Phase 3 analysis, the effectiveness rate of MRNA-1273 is 94.5 percent," the company said in a statement. Last week, Pfizer and Biontech announced that the vaccine they developed was 90 percent effective.

It was declared 94.5 percent effective. "These are two excellent vaccines that will help many people in the United States and around the world," Bancel said. Bancel said it was too early to compare the vaccine to Pfizer's BioNTech vaccine. Moderna's vaccine has a significant advantage over the Pfizer/BioNTech vaccine, he said. 

Moderna's vaccine can be kept for a month at typical refrigerator temperatures (2-8 degrees), while Pfizer's shot should be stored at -70 degrees, which requires dry ice and special containers, it said."I believe that by Memorial Day, everyone will get the vaccine," said Stephane Bancel, CEO of Moderna, who said that by June, a Coronavirus vaccine will be available to every U.S. citizen who wants it. 

"I believe that by Memorial Day, anyone who wants a vaccine in the U.S. will have a safe and effective vaccine," said Bancel, who shared his predictions about the U.S. returning to normal in the summer of 2021. Memorial Day, which marks the unofficial start of summer for the US, will be held on May 31 next year. The vaccine developed by BIONTECH and Pfizer was 90% effective. Dr. Ugur Sahin and Prof. Dr. The coronavirus vaccine developed by BioNTech and Pfizer, founded by Ozlem Tureci, was also announced to be 90 percent effective.